598 results on '"Bilezikian J"'
Search Results
2. Evolving concepts in ventral hernia repair and physical therapy: prehabilitation, rehabilitation, and analogies to tendon reconstruction
3. Comparing the outcomes of external oblique and transversus abdominus release using the AHSQC database
4. Hypercalciuria: its value as a predictive risk factor for nephrolithiasis in asymptomatic primary hyperparathyroidism?
5. Consensus statement from 2nd International Conference on Controversies in Vitamin D
6. The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group.
7. Primary non-complicated midline ventral hernia: overview of approaches and controversies
8. Hypercalciuria: its value as a predictive risk factor for nephrolithiasis in asymptomatic primary hyperparathyroidism?
9. Bone imaging in hypoparathyroidism
10. Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus
11. Epidemiology of hip fracture in Belarus: development of a country-specific FRAX model and its comparison to neighboring country models
12. Low vitamin D levels have become less common in primary hyperparathyroidism
13. Taxonomy of rare genetic metabolic bone disorders
14. A trabecular plate-like phenotype is overrepresented in Chinese-American versus Caucasian women
15. Relationship of Bone Mineralization Density Distribution (BMDD) in Cortical and Cancellous Bone Within the Iliac Crest of Healthy Premenopausal Women
16. The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group
17. Comparison of two commercially available ELISAs for circulating sclerostin
18. β-adrenergic receptor antagonists and fracture risk: a meta-analysis of selectivity, gender, and site-specific effects
19. Use of parathyroid hormone in hypoparathyroidism
20. The Anabolic Effects of Parathyroid Hormone
21. Correlation between 25-hydroxyvitamin D levels and latitude in Brazilian postmenopausal women: from the Arzoxifene Generations Trial
22. Improved adherence with PTH(1–84) in an extension trial for 24 months results in enhanced BMD gains in the treatment of postmenopausal women with osteoporosis
23. Treatment failure in osteoporosis
24. An appendix to the 2012 IOF–ECTS guidelines for the management of glucocorticoid-induced osteoporosis
25. DXA-based Bone Strain Index: A New Tool to Evaluate Bone Quality in Primary Hyperparathyroidism
26. Volumetric bone mineral density at the spine and hip in Chinese American and White women
27. A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis
28. What’s in a name? What constitutes the clinical diagnosis of osteoporosis?
29. New understanding and treatments for osteoporosis
30. Catabolic and anabolic actions of parathyroid hormone on the skeleton
31. Towards a diagnostic and therapeutic consensus in male osteoporosis
32. Interpretation and use of FRAX in clinical practice
33. Therapy of hypoparathyroidism with intact parathyroid hormone
34. Fragility fractures of the hip and femur: incidence and patient characteristics
35. Assessment of trabecular and cortical architecture and mechanical competence of bone by high-resolution peripheral computed tomography: comparison with transiliac bone biopsy
36. Effects of Rosiglitazone vs Metformin on Circulating Osteoclast and Osteogenic Precursor Cells in Postmenopausal Women with Type 2 Diabetes Mellitus
37. Denosumab Restores Cortical Bone Loss at the Distal Radius Associated with Aging and Reduces Wrist Fracture Risk. Analyses from the Cross-over Group in the Extension of Denosumab Pivotal Fracture Trial.: 1795
38. Hyperparathyroidism 2 gene (HRPT2, CDC73) and parafibromin studies in two patients with primary hyperparathyroidism and uncertain pathological assessment
39. Special report on the 2007 adult and pediatric Position Development Conferences of the International Society for Clinical Densitometry
40. Glucocorticoid-induced osteoporosis: pathophysiology and therapy
41. Hetereogeneity in skeletal response to full-length parathyroid hormone in the treatment of osteoporosis
42. Determinants of bone mineral density in Chinese-American women
43. A referent bone mineral density database for Chinese American women
44. Erratum to: Taxonomy of rare genetic metabolic bone disorders
45. JCEM ARCHIVECinacalcet Hydrochloride Reduces the Serum Calcium Concentration in Inoperable Parathyroid Carcinoma
46. Denosumab for the Treatment of Osteoporosis and Cancer-Related Conditions
47. Influence of Antiresorptive Agent OST-766 on Signal Transduction Pathways Involved in Parathyroid Hormone Action
48. “Evidence-based” or “logic-based” medicine?
49. A randomized, parallel group, double-blind, multicentre study comparing the efficacy and safety of Avandamet (rosiglitazone/metformin) and metformin on long-term glycaemic control and bone mineral density after 80 weeks of treatment in drug-naïve type 2 diabetes mellitus patients
50. Cinacalcet HCl Reduces Hypercalcemia in Primary Hyperparathyroidism across a Wide Spectrum of Disease Severity
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.